Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06770062 · ClinicalTrials.gov registry record
Multimodality Evaluation of Left Ventricular Remodeling In Mitral Regurgitation: A Pilot Study
A clinical trial of Left Ventricular Systolic Dysfunction, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT06770062: Recruiting study of Left Ventricular Systolic Dysfunction, sponsored by Mayo Clinic.
NCT06770062 is a study of Left Ventricular Systolic Dysfunction that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06770062, a study of Left Ventricular Systolic Dysfunction, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to determine the feasibility of a larger, future study proposing a multimodal approach using cardiac CT and MRI to assess the risk of developing left ventricular (LV) systolic dysfunction in patients with mitral regurgitation (MR).
Primary Outcome
Number of subjects consented to participate in study
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Cardiac MRI
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-01-20 |
| Est. Completion | 2027-12 |
What NCT06770062 shows while recruiting
NCT06770062 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 1 condition, with Left Ventricular Systolic Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which Cardiac MRI is the first listed.
NCT06770062 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06770062 about?
NCT06770062 is a clinical study titled "Multimodality Evaluation of Left Ventricular Remodeling In Mitral Regurgitation: A Pilot Study". The purpose of this research is to determine the feasibility of a larger, future study proposing a multimodal approach using cardiac CT and MRI to assess the risk of developing left ventricular (LV) systolic dysfunction in patients with mitral regurgitation (MR).
What is the current status of trial NCT06770062?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2025-01-20. Estimated completion is 2027-12.
What conditions does trial NCT06770062 study?
This clinical trial studies the following conditions: Left Ventricular Systolic Dysfunction.
What interventions are being tested in trial NCT06770062?
The interventions under investigation include: Cardiac MRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06770062?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06770062 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Left Ventricular Systolic Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
RECRUITING · Phase 3
-
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI